{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "the-united-states", "type": "definition", "offset": [6, 23]}, {"key": "food-and-drug-administration", "type": "definition", "offset": [24, 52]}, {"key": "successor-agency", "type": "definition", "offset": [61, 77]}], "size": 6519, "samples": [{"hash": "komvCthxGS7", "uri": "/contracts/komvCthxGS7#fda", "label": "Exclusive Collaboration Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}, {"hash": "fqM9ElDVwT4", "uri": "/contracts/fqM9ElDVwT4#fda", "label": "Collaboration Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}, {"hash": "2DaoFn5XB5E", "uri": "/contracts/2DaoFn5XB5E#fda", "label": "Exclusive License and Development Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}], "snippet": "means the United States Food and Drug Administration and any successor agency thereto.", "hash": "d674ee65e3b6f704bc56a1f8171d8471", "id": 1}, {"snippet_links": [{"key": "the-united-states", "type": "definition", "offset": [6, 23]}, {"key": "food-and-drug-administration", "type": "definition", "offset": [24, 52]}], "size": 5391, "samples": [{"hash": "d1gGfZxTmpu", "uri": "/contracts/d1gGfZxTmpu#fda", "label": "Stock Purchase Agreement (USBC, Inc.)", "score": 37.2491444216, "published": true}, {"hash": "7IZvvayiFIR", "uri": "/contracts/7IZvvayiFIR#fda", "label": "Securities Purchase Agreement (NewcelX Ltd.)", "score": 37.2464065552, "published": true}, {"hash": "2yQtp0vWQW5", "uri": "/contracts/2yQtp0vWQW5#fda", "label": "License Agreement (Evogene Ltd.)", "score": 37.2299804688, "published": true}], "snippet": "means the United States Food and Drug Administration.", "hash": "41e32a2edec6bf7d1ec26fe16e8d5151", "id": 2}, {"snippet_links": [{"key": "the-us", "type": "clause", "offset": [6, 13]}, {"key": "food-and-drug-administration", "type": "definition", "offset": [15, 43]}, {"key": "successor-entity", "type": "definition", "offset": [51, 67]}], "size": 2382, "samples": [{"hash": "cWj38TBAD3Z", "uri": "/contracts/cWj38TBAD3Z#fda", "label": "Exclusive License Agreement (VYNE Therapeutics Inc.)", "score": 37.2436676025, "published": true}, {"hash": "4huTrMoOXBX", "uri": "/contracts/4huTrMoOXBX#fda", "label": "License and Collaboration Agreement (Kailera Therapeutics, Inc.)", "score": 37.2327156067, "published": true}, {"hash": "6NLXC8Gf89S", "uri": "/contracts/6NLXC8Gf89S#fda", "label": "Exclusive License Agreement (VYNE Therapeutics Inc.)", "score": 37.0793991089, "published": true}], "snippet": "means the U.S. Food and Drug Administration or any successor entity.", "hash": "a34b7b0511a6df06de804be7c7869197", "id": 3}, {"snippet_links": [], "size": 1984, "samples": [{"hash": "dxQWRCeT1Qt", "uri": "/contracts/dxQWRCeT1Qt#fda", "label": "Securities Purchase Agreement (Auddia Inc.)", "score": 37.2518822724, "published": true}, {"hash": "2B24VpnGJPg", "uri": "/contracts/2B24VpnGJPg#fda", "label": "Securities Purchase Agreement (Hoth Therapeutics, Inc.)", "score": 37.2491444216, "published": true}, {"hash": "a2fXr7xiNDI", "uri": "/contracts/a2fXr7xiNDI#fda", "label": "Securities Purchase Agreement (Aprea Therapeutics, Inc.)", "score": 37.2409324646, "published": true}], "snippet": "shall have the meaning ascribed to such term in Section 3.1(hh).", "hash": "8fb187e4b15c4fe8e3e0d225ec893353", "id": 4}, {"snippet_links": [{"key": "the-united-states", "type": "definition", "offset": [6, 23]}, {"key": "food-and-drug-administration", "type": "definition", "offset": [24, 52]}, {"key": "successor-agency", "type": "definition", "offset": [61, 77]}, {"key": "same-or-similar", "type": "definition", "offset": [89, 104]}], "size": 597, "samples": [{"hash": "j4wPbFdYqW3", "uri": "/contracts/j4wPbFdYqW3#fda", "label": "Clinical Trial Collaboration Agreement (I-Mab)", "score": 36.2525672913, "published": true}, {"hash": "6PkfvsC7mYy", "uri": "/contracts/6PkfvsC7mYy#fda", "label": "Clinical Trial Collaboration Agreement (Dermata Therapeutics, Inc.)", "score": 36.0554428101, "published": true}, {"hash": "g0RNXCimZiV", "uri": "/contracts/g0RNXCimZiV#fda", "label": "Research and Development Collaboration and Option Agreement (Molecular Partners Ag)", "score": 35.1984939575, "published": true}], "snippet": "means the United States Food and Drug Administration, or any successor agency having the same or similar authority.", "hash": "15751d6e0453b6d29af5d8aeaf4c8ac3", "id": 5}, {"snippet_links": [{"key": "the-united-states", "type": "definition", "offset": [6, 23]}, {"key": "food-and-drug-administration", "type": "definition", "offset": [24, 52]}], "size": 570, "samples": [{"hash": "kdO5ZNnvdcB", "uri": "/contracts/kdO5ZNnvdcB#fda", "label": "Collaboration and License Agreement (4D Molecular Therapeutics, Inc.)", "score": 37.2080764771, "published": true}, {"hash": "YVxv6bPJ0r", "uri": "/contracts/YVxv6bPJ0r#fda", "label": "Collaboration, License and Option Agreement (Xilio Therapeutics, Inc.)", "score": 36.3483924866, "published": true}, {"hash": "9EEmS4As4wR", "uri": "/contracts/9EEmS4As4wR#fda", "label": "License and Collaboration Agreement (PTC Therapeutics, Inc.)", "score": 36.1567420959, "published": true}], "snippet": "means the United States Food and Drug Administration and any successor agency(ies) or authority having substantially the same function.", "hash": "d54b03646884922b4050a8ab3cbc770f", "id": 6}, {"snippet_links": [{"key": "food-and-drug-administration", "type": "definition", "offset": [24, 52]}, {"key": "successor-agency", "type": "definition", "offset": [61, 77]}, {"key": "authority-to", "type": "definition", "offset": [112, 124]}, {"key": "pharmaceutical-products", "type": "definition", "offset": [157, 180]}, {"key": "therapeutic-products", "type": "clause", "offset": [195, 215]}, {"key": "delivery-systems", "type": "definition", "offset": [217, 233]}, {"key": "the-united-states-of-america", "type": "clause", "offset": [249, 277]}], "size": 371, "samples": [{"hash": "5bRzmQR0OT8", "uri": "/contracts/5bRzmQR0OT8#fda", "label": "Merger Agreement (Penumbra Inc)", "score": 37.0383300781, "published": true}, {"hash": "1xmuNqhpVVG", "uri": "/contracts/1xmuNqhpVVG#fda", "label": "Merger Agreement (Boston Scientific Corp)", "score": 37.0383300781, "published": true}, {"hash": "jzaH0JRt6l1", "uri": "/contracts/jzaH0JRt6l1#fda", "label": "Merger Agreement (Stryker Corp)", "score": 36.0171127319, "published": true}], "snippet": "means the United States Food and Drug Administration, or any successor agency thereto having the administrative authority to regulate the marketing of human pharmaceutical products or biological therapeutic products, delivery systems and devices in the United States of America.", "hash": "6e2b5c64d43b3210a9ee81b3a6f2f386", "id": 7}, {"snippet_links": [], "size": 309, "samples": [{"hash": "aM8yxgh7JGD", "uri": "/contracts/aM8yxgh7JGD#fda", "label": "Securities Purchase Agreement (HCW Biologics Inc.)", "score": 37.1341552734, "published": true}, {"hash": "k4katiSRCpD", "uri": "/contracts/k4katiSRCpD#fda", "label": "Securities Purchase Agreement (HCW Biologics Inc.)", "score": 37.1286773682, "published": true}, {"hash": "jcdFKsiE9Qf", "uri": "/contracts/jcdFKsiE9Qf#fda", "label": "Securities Purchase Agreement (HCW Biologics Inc.)", "score": 37.1122512817, "published": true}], "snippet": "shall have the meaning ascribed to such term in Section 3.1(hh). \u201cFDCA\u201d shall have the meaning ascribed to such term in Section 3.1(hh). \u201cGAAP\u201d shall have the meaning ascribed to such term in Section 3.1(h).", "hash": "18d80fcdbffc0abf5ef3b572cf1400ac", "id": 8}, {"snippet_links": [{"key": "food-and-drug-administration", "type": "definition", "offset": [18, 46]}], "size": 264, "samples": [{"hash": "k15jKlImXF0", "uri": "/contracts/k15jKlImXF0#fda", "label": "Member Contract", "score": 24.0636558533, "published": true}, {"hash": "bh5G7lxFLVc", "uri": "/contracts/bh5G7lxFLVc#fda", "label": "Member Contract", "score": 24.0636558533, "published": true}, {"hash": "jMpbXpD8nev", "uri": "/contracts/jMpbXpD8nev#fda", "label": "Contract Amendment", "score": 23.7118415833, "published": true}], "snippet": "means the federal Food and Drug Administration.", "hash": "b0365a83e7534ead5f2ba96aecd1c520", "id": 9}, {"snippet_links": [{"key": "the-united-states", "type": "definition", "offset": [6, 23]}, {"key": "food-and-drug-administration", "type": "definition", "offset": [24, 52]}, {"key": "successor-agency", "type": "definition", "offset": [62, 78]}], "size": 167, "samples": [{"hash": "gE7oL3HD8uT", "uri": "/contracts/gE7oL3HD8uT#fda", "label": "Manufacturing and Supply Agreement (Mallinckrodt PLC)", "score": 36.8576316833, "published": true}, {"hash": "fuGeE5jVNSi", "uri": "/contracts/fuGeE5jVNSi#fda", "label": "Lenacapavir License Agreement", "score": 35.4754676819, "published": true}, {"hash": "caROjOPP8kY", "uri": "/contracts/caROjOPP8kY#fda", "label": "Lenacapavir License Agreement", "score": 35.4363594055, "published": true}], "snippet": "means the United States Food and Drug Administration, and any successor agency thereto.", "hash": "e819413499a02ce6ce622f48075909a9", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMZmRhIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "FDA", "size": 22626, "snippet": "means the United States Food and Drug Administration and any successor agency thereto.", "id": "fda", "examples": ["The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the <strong>FDA</strong> and EMA.", "Neither the Company nor any of its Subsidiaries has received any Form <strong>FDA</strong> 483, warning letter, untitled letter or other correspondence or written notice from any Governmental Authority, alleging or asserting noncompliance with the Federal Food, Drug, and Cosmetic Act (21 U.S.C. \u00a7 301 et seq.) (\u201cFDCA\u201d) or comparable foreign Laws.", "The Company has not been informed by the <strong>FDA</strong> that the <strong>FDA</strong> will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the <strong>FDA</strong> expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company."], "related": [["mfda", "MFDA", "MFDA"], ["drug-abuse", "Drug abuse", "Drug abuse"], ["cfda", "CFDA", "CFDA"], ["drug-approval-application", "Drug Approval Application", "Drug Approval Application"], ["regulatory-authorities", "Regulatory Authorities", "Regulatory Authorities"]], "related_snippets": [], "updated": "2026-04-05T05:49:25+00:00"}, "json": true, "cursor": ""}}